ApoB and non-HDL-c are better markers of residual risk than LDL-c in statin-treated patients
Elevated levels of apoB and non-HDL-c better reflect residual risk for all-cause mortality and MI than LDL-c levels in patients treated with statins.
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated PatientsLiterature - Johannesen CDL, Mortensen MB, Langsted A et al. - J Am Coll Cardiol. 2...
jacc.org